Clinical trials
Dyslipidemia clinical trials
Below are recruiting dyslipidemia clinical trials, each written for real people, not researchers. We’re tracking 85 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07614958RecruitingPhase 3
Testing a new cholesterol medicine against bempedoic acid
This study compares two new medicines—obicetrapib and bempedoic acid—to see which one better lowers cholesterol in people whose cholesterol remains high despite taking standard medications. If your cholesterol isn't controlled well enough with current drugs, this trial may help you access an experimental treatment.
Stockton-on-TeesAges 18 years+ - NCT03449784Recruiting
Checks how well cholesterol treatment follows guidelines
This study looks at whether treatment for cholesterol and related fats matches European and French medical guidelines. It uses blood tests taken soon after hospital admission to understand current care and may help improve how patients are treated.
MontpellierAges 18 years+ - NCT06463561RecruitingPhase 4
CPAP for high cholesterol and sleep apnea
This study tests if CPAP therapy can improve cholesterol and uric acid levels in people with both high cholesterol and moderate to severe sleep apnea. It may help if you have sleep apnea and are looking for additional ways to manage your lipid levels.
Coslada, MadridAges 35–80 - NCT07803822RecruitingPhase 2
New drug alone or with inclisiran for high cholesterol and triglycerides
This study tests a new investigational drug called MWX203, given alone or with another medicine (inclisiran), to lower both 'bad' cholesterol (LDL) and triglycerides in people with mixed dyslipidemia. The goal is to see if the combination is safe and works better than statins alone.
Beijing, Beijing MunicipalityAges 18–75 - NCT06293417Recruiting
Study of Ezefeno in patients with high cholesterol and type 2 diabetes
This trial tests a medicine called Ezefeno to see if it helps lower cholesterol in people with type 2 diabetes who are already on statins. It may be an option if you have high triglycerides and other heart risk factors.
SeoulAges 19 years+ - NCT07543718Recruiting
Group Medical Visits for High Cholesterol Management
This trial tests whether attending group medical visits with other patients can help manage high cholesterol levels. You'll meet with a healthcare team and peers to learn about cholesterol and how to control it together.
Dieppe, New BrunswickAges 40 years+ - NCT07523971Recruiting
Pitavastatin/Ezetimibe for High Cholesterol and Metabolic Syndrome
This study watches how well a combination cholesterol medication (pitavastatin and ezetimibe) works in people who have high cholesterol and metabolic syndrome (a cluster of health issues including high blood pressure, blood sugar, and cholesterol). You'll be monitored over time to see if the medication helps and is safe for you.
DaejeonAges 19 years+ - NCT07491172RecruitingPhase 1
Trial of CTX310 for stubborn high cholesterol and fats
This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.
Hialeah, FloridaAges 18–75 - NCT07045623Recruiting
Better care and education for high cholesterol
This study compares two ways of managing high cholesterol: a more intensive program with extra support versus the usual care and education. It's for people with high blood pressure or diabetes who are already part of a community health program.
Gyeonggi-do, Suwon-siAges 30–80 - NCT06980428RecruitingPhase 1
Safety study of AZD4954 in people with or without high Lp(a)
This trial tests a new drug called AZD4954 for safety. It includes healthy volunteers and people with high Lp(a) or dyslipidemia. The goal is to see if the drug is safe and how the body processes it.
Glendale, CaliforniaAges 18–70 - NCT06797401RecruitingPhase 2
RBD5044 for mixed high cholesterol and triglycerides
This trial tests a new medication called RBD5044 for people with mixed dyslipidemia (high levels of fats and cholesterol in the blood). It may help lower triglycerides and cholesterol when statins aren't enough.
LundAges 18–80 - NCT06772168RecruitingPhase 3
New combo pill for diabetes and high cholesterol
This trial tests a new combination pill for people with type 2 diabetes and high cholesterol who are already on metformin. It aims to see if the new drug helps control both blood sugar and cholesterol better than current treatments.
AnyangAges 19–80 - NCT06676046Recruiting
Study of rare cholesterol and fat disorders
This study looks at people with rare or unusual cholesterol, fat, or heart-related conditions. It helps researchers learn more about these disorders and improve testing. You do not need to have a known diagnosis to join initially.
Bethesda, MarylandAges 10–90 - NCT06643130RecruitingPhase 3
Testing a combo treatment for high blood pressure and cholesterol
This study tests whether adding two medications together helps people who have both high blood pressure and high cholesterol. It aims to see if the combination works better and is safe.
SeoulAges 19 years+ - NCT06183307Recruiting
Nattokinase for heart health in people with high cholesterol
This trial tests whether nattokinase, a natural enzyme, can reduce inflammation and improve heart health in people with high cholesterol or high triglycerides. If you have elevated LDL or triglycerides, you may be eligible even if you are already taking cholesterol medication.
Rio de Janeiro, Rio de JaneiroAges 18 years+ - NCT04602754RecruitingPhase 3
Oral treatment test for type 2 diabetes and bad cholesterol
This Phase 3 study tests whether Berlim 25/20 can improve blood sugar control and cholesterol (LDL) in adults with type 2 diabetes who haven’t met targets despite prior lifestyle guidance and treatment. It also looks at safety, including effects on the heart and medication-related side effects.
Campinas, São PauloAges 18–85 - NCT05365425RecruitingPhase 4
Choline fenofibrate to reduce plaque in type 2 diabetes
This trial studies whether choline fenofibrate can improve blood vessel plaque (carotid artery plaque) in people with type 2 diabetes and mixed cholesterol problems. It aims to see if the medicine can make carotid plaque thinner or otherwise healthier while keeping safety in mind.
Seongnam-si, Gyeonggi-doAges 20 years+ - NCT05365438RecruitingPhase 4
Atorvastatin plus omega-3 for artery plaque in type 2 diabetes
This trial studies whether a combination of atorvastatin and omega-3 can reduce signs of artery plaque in people with type 2 diabetes and “mixed” cholesterol problems. It’s focused on people who don’t have symptoms from plaque yet.
Seongnam-si, Gyeonggi-doAges 20–80 - NCT04209816Enrolling by invitation
Genetics study on fatty liver and cholesterol problems
This is a research study testing whether specific gene changes are linked to fatty liver and a cholesterol pattern that raises heart risk. It may help researchers understand who is most likely to develop these conditions and why, which could guide future prevention.
HelsinkiAges 18–70 - NCT05994274Recruiting
Heart transplant, cholesterol, and organ rejection study
This study looks at whether changes in blood fats (cholesterol and triglycerides) after a heart transplant are linked to the risk of organ rejection. It may help doctors better monitor and protect your new heart.
WuhanAges 18 years+ - NCT06409962Recruiting
New school program for childhood obesity and prediabetes
This study tests a new program to help children with obesity, focusing on those with slightly higher blood sugar (prediabetes). It takes place at a school and requires both parent and child consent.
CórdobaAges 6–16 - NCT07824323RecruitingPhase 4
Early cholesterol treatment after a heart attack
This study tests whether adding an extra cholesterol-lowering drug (bempedoic acid) to the usual treatment soon after a heart attack or related event can lower 'bad' cholesterol more effectively. It may help reduce the risk of future heart problems.
Taipei, Taipei CityAges 18 years+ - NCT07742488Recruiting
Statins and hormone therapy for cholesterol in menopause
This study looks at whether taking statins (cholesterol-lowering medicine) along with hormone replacement therapy (HRT) affects blood clotting in women going through menopause who have high cholesterol. It may help doctors understand how these medicines work together.
Pisa, ItalyAges 45–55 - NCT07703371Recruiting
Kodo millet porridge and its effect on gut health and metabolic syndrome
This study tests whether eating Kodo millet porridge every day for 12 weeks can improve gut health and reduce risk factors for metabolic syndrome (like being overweight). If you are between 20 and 60 years old, are overweight or obese, and are willing to eat the porridge daily without changing your diet or exercise, you may be able to join.
Mysore, KarnatakaAges 20–60
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Dyslipidemia trials by city
Studies with a site in or near these metro areas.
Dyslipidemia trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for dyslipidemia?
- Yes. Clin2 currently lists 85 recruiting dyslipidemia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a dyslipidemia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a dyslipidemia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.